Global Insomnia Therapeutics Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Insomnia Therapeutics Drugs Market Size was estimated at USD 3042.26 million in 2023 and is projected to reach USD 3718.09 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.
This report provides a deep insight into the global Insomnia Therapeutics Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insomnia Therapeutics Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insomnia Therapeutics Drugs market in any manner.
Global Insomnia Therapeutics Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Market Segmentation (by Type)
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Market Segmentation (by Application)
Prescription
Over-the-Counter (OTC)
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Insomnia Therapeutics Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Insomnia Therapeutics Drugs Market Size was estimated at USD 3042.26 million in 2023 and is projected to reach USD 3718.09 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.
This report provides a deep insight into the global Insomnia Therapeutics Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insomnia Therapeutics Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insomnia Therapeutics Drugs market in any manner.
Global Insomnia Therapeutics Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Market Segmentation (by Type)
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Market Segmentation (by Application)
Prescription
Over-the-Counter (OTC)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Insomnia Therapeutics Drugs Market
- Overview of the regional outlook of the Insomnia Therapeutics Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Insomnia Therapeutics Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Insomnia Therapeutics Drugs
1.2 Key Market Segments
1.2.1 Insomnia Therapeutics Drugs Segment by Type
1.2.2 Insomnia Therapeutics Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INSOMNIA THERAPEUTICS DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Insomnia Therapeutics Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Insomnia Therapeutics Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INSOMNIA THERAPEUTICS DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Insomnia Therapeutics Drugs Sales by Manufacturers (2019-2024)
3.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Insomnia Therapeutics Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Insomnia Therapeutics Drugs Sales Sites, Area Served, Product Type
3.6 Insomnia Therapeutics Drugs Market Competitive Situation and Trends
3.6.1 Insomnia Therapeutics Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Insomnia Therapeutics Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INSOMNIA THERAPEUTICS DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Insomnia Therapeutics Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INSOMNIA THERAPEUTICS DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INSOMNIA THERAPEUTICS DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Insomnia Therapeutics Drugs Sales Market Share by Type (2019-2024)
6.3 Global Insomnia Therapeutics Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Insomnia Therapeutics Drugs Price by Type (2019-2024)
7 INSOMNIA THERAPEUTICS DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Insomnia Therapeutics Drugs Market Sales by Application (2019-2024)
7.3 Global Insomnia Therapeutics Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Insomnia Therapeutics Drugs Sales Growth Rate by Application (2019-2024)
8 INSOMNIA THERAPEUTICS DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Insomnia Therapeutics Drugs Sales by Region
8.1.1 Global Insomnia Therapeutics Drugs Sales by Region
8.1.2 Global Insomnia Therapeutics Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Insomnia Therapeutics Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Insomnia Therapeutics Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Insomnia Therapeutics Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Insomnia Therapeutics Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Insomnia Therapeutics Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda Pharmaceutical Company Ltd.
9.1.1 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Basic Information
9.1.2 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product Overview
9.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product Market Performance
9.1.4 Takeda Pharmaceutical Company Ltd. Business Overview
9.1.5 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs SWOT Analysis
9.1.6 Takeda Pharmaceutical Company Ltd. Recent Developments
9.2 Vanda Pharmaceuticals
9.2.1 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Basic Information
9.2.2 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product Overview
9.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product Market Performance
9.2.4 Vanda Pharmaceuticals Business Overview
9.2.5 Vanda Pharmaceuticals Insomnia Therapeutics Drugs SWOT Analysis
9.2.6 Vanda Pharmaceuticals Recent Developments
9.3 Merck and Co., Inc.
9.3.1 Merck and Co., Inc. Insomnia Therapeutics Drugs Basic Information
9.3.2 Merck and Co., Inc. Insomnia Therapeutics Drugs Product Overview
9.3.3 Merck and Co., Inc. Insomnia Therapeutics Drugs Product Market Performance
9.3.4 Merck and Co., Inc. Insomnia Therapeutics Drugs SWOT Analysis
9.3.5 Merck and Co., Inc. Business Overview
9.3.6 Merck and Co., Inc. Recent Developments
9.4 Pfizer Inc.
9.4.1 Pfizer Inc. Insomnia Therapeutics Drugs Basic Information
9.4.2 Pfizer Inc. Insomnia Therapeutics Drugs Product Overview
9.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Product Market Performance
9.4.4 Pfizer Inc. Business Overview
9.4.5 Pfizer Inc. Recent Developments
9.5 Teva Pharmaceutical Industries Ltd.
9.5.1 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Basic Information
9.5.2 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product Overview
9.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product Market Performance
9.5.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.6 Mylan N.V.
9.6.1 Mylan N.V. Insomnia Therapeutics Drugs Basic Information
9.6.2 Mylan N.V. Insomnia Therapeutics Drugs Product Overview
9.6.3 Mylan N.V. Insomnia Therapeutics Drugs Product Market Performance
9.6.4 Mylan N.V. Business Overview
9.6.5 Mylan N.V. Recent Developments
9.7 Sumitomo Dainippon Pharma Co., Ltd
9.7.1 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Basic Information
9.7.2 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product Overview
9.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product Market Performance
9.7.4 Sumitomo Dainippon Pharma Co., Ltd Business Overview
9.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
9.8 Sanofi
9.8.1 Sanofi Insomnia Therapeutics Drugs Basic Information
9.8.2 Sanofi Insomnia Therapeutics Drugs Product Overview
9.8.3 Sanofi Insomnia Therapeutics Drugs Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
9.9 Paratek Pharmaceuticals Inc.
9.9.1 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Basic Information
9.9.2 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product Overview
9.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product Market Performance
9.9.4 Paratek Pharmaceuticals Inc. Business Overview
9.9.5 Paratek Pharmaceuticals Inc. Recent Developments
9.10 Ebb Therapeutics
9.10.1 Ebb Therapeutics Insomnia Therapeutics Drugs Basic Information
9.10.2 Ebb Therapeutics Insomnia Therapeutics Drugs Product Overview
9.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Product Market Performance
9.10.4 Ebb Therapeutics Business Overview
9.10.5 Ebb Therapeutics Recent Developments
10 INSOMNIA THERAPEUTICS DRUGS MARKET FORECAST BY REGION
10.1 Global Insomnia Therapeutics Drugs Market Size Forecast
10.2 Global Insomnia Therapeutics Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Insomnia Therapeutics Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Insomnia Therapeutics Drugs Market Size Forecast by Region
10.2.4 South America Insomnia Therapeutics Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Insomnia Therapeutics Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Insomnia Therapeutics Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Insomnia Therapeutics Drugs by Type (2025-2030)
11.1.2 Global Insomnia Therapeutics Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Insomnia Therapeutics Drugs by Type (2025-2030)
11.2 Global Insomnia Therapeutics Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Insomnia Therapeutics Drugs Sales (K Units) Forecast by Application
11.2.2 Global Insomnia Therapeutics Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Insomnia Therapeutics Drugs
1.2 Key Market Segments
1.2.1 Insomnia Therapeutics Drugs Segment by Type
1.2.2 Insomnia Therapeutics Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INSOMNIA THERAPEUTICS DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Insomnia Therapeutics Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Insomnia Therapeutics Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INSOMNIA THERAPEUTICS DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Insomnia Therapeutics Drugs Sales by Manufacturers (2019-2024)
3.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Insomnia Therapeutics Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Insomnia Therapeutics Drugs Sales Sites, Area Served, Product Type
3.6 Insomnia Therapeutics Drugs Market Competitive Situation and Trends
3.6.1 Insomnia Therapeutics Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Insomnia Therapeutics Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INSOMNIA THERAPEUTICS DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Insomnia Therapeutics Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INSOMNIA THERAPEUTICS DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INSOMNIA THERAPEUTICS DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Insomnia Therapeutics Drugs Sales Market Share by Type (2019-2024)
6.3 Global Insomnia Therapeutics Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Insomnia Therapeutics Drugs Price by Type (2019-2024)
7 INSOMNIA THERAPEUTICS DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Insomnia Therapeutics Drugs Market Sales by Application (2019-2024)
7.3 Global Insomnia Therapeutics Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Insomnia Therapeutics Drugs Sales Growth Rate by Application (2019-2024)
8 INSOMNIA THERAPEUTICS DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Insomnia Therapeutics Drugs Sales by Region
8.1.1 Global Insomnia Therapeutics Drugs Sales by Region
8.1.2 Global Insomnia Therapeutics Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Insomnia Therapeutics Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Insomnia Therapeutics Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Insomnia Therapeutics Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Insomnia Therapeutics Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Insomnia Therapeutics Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda Pharmaceutical Company Ltd.
9.1.1 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Basic Information
9.1.2 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product Overview
9.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product Market Performance
9.1.4 Takeda Pharmaceutical Company Ltd. Business Overview
9.1.5 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs SWOT Analysis
9.1.6 Takeda Pharmaceutical Company Ltd. Recent Developments
9.2 Vanda Pharmaceuticals
9.2.1 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Basic Information
9.2.2 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product Overview
9.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product Market Performance
9.2.4 Vanda Pharmaceuticals Business Overview
9.2.5 Vanda Pharmaceuticals Insomnia Therapeutics Drugs SWOT Analysis
9.2.6 Vanda Pharmaceuticals Recent Developments
9.3 Merck and Co., Inc.
9.3.1 Merck and Co., Inc. Insomnia Therapeutics Drugs Basic Information
9.3.2 Merck and Co., Inc. Insomnia Therapeutics Drugs Product Overview
9.3.3 Merck and Co., Inc. Insomnia Therapeutics Drugs Product Market Performance
9.3.4 Merck and Co., Inc. Insomnia Therapeutics Drugs SWOT Analysis
9.3.5 Merck and Co., Inc. Business Overview
9.3.6 Merck and Co., Inc. Recent Developments
9.4 Pfizer Inc.
9.4.1 Pfizer Inc. Insomnia Therapeutics Drugs Basic Information
9.4.2 Pfizer Inc. Insomnia Therapeutics Drugs Product Overview
9.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Product Market Performance
9.4.4 Pfizer Inc. Business Overview
9.4.5 Pfizer Inc. Recent Developments
9.5 Teva Pharmaceutical Industries Ltd.
9.5.1 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Basic Information
9.5.2 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product Overview
9.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product Market Performance
9.5.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.6 Mylan N.V.
9.6.1 Mylan N.V. Insomnia Therapeutics Drugs Basic Information
9.6.2 Mylan N.V. Insomnia Therapeutics Drugs Product Overview
9.6.3 Mylan N.V. Insomnia Therapeutics Drugs Product Market Performance
9.6.4 Mylan N.V. Business Overview
9.6.5 Mylan N.V. Recent Developments
9.7 Sumitomo Dainippon Pharma Co., Ltd
9.7.1 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Basic Information
9.7.2 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product Overview
9.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product Market Performance
9.7.4 Sumitomo Dainippon Pharma Co., Ltd Business Overview
9.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
9.8 Sanofi
9.8.1 Sanofi Insomnia Therapeutics Drugs Basic Information
9.8.2 Sanofi Insomnia Therapeutics Drugs Product Overview
9.8.3 Sanofi Insomnia Therapeutics Drugs Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
9.9 Paratek Pharmaceuticals Inc.
9.9.1 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Basic Information
9.9.2 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product Overview
9.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product Market Performance
9.9.4 Paratek Pharmaceuticals Inc. Business Overview
9.9.5 Paratek Pharmaceuticals Inc. Recent Developments
9.10 Ebb Therapeutics
9.10.1 Ebb Therapeutics Insomnia Therapeutics Drugs Basic Information
9.10.2 Ebb Therapeutics Insomnia Therapeutics Drugs Product Overview
9.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Product Market Performance
9.10.4 Ebb Therapeutics Business Overview
9.10.5 Ebb Therapeutics Recent Developments
10 INSOMNIA THERAPEUTICS DRUGS MARKET FORECAST BY REGION
10.1 Global Insomnia Therapeutics Drugs Market Size Forecast
10.2 Global Insomnia Therapeutics Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Insomnia Therapeutics Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Insomnia Therapeutics Drugs Market Size Forecast by Region
10.2.4 South America Insomnia Therapeutics Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Insomnia Therapeutics Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Insomnia Therapeutics Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Insomnia Therapeutics Drugs by Type (2025-2030)
11.1.2 Global Insomnia Therapeutics Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Insomnia Therapeutics Drugs by Type (2025-2030)
11.2 Global Insomnia Therapeutics Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Insomnia Therapeutics Drugs Sales (K Units) Forecast by Application
11.2.2 Global Insomnia Therapeutics Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Insomnia Therapeutics Drugs Market Size Comparison by Region (M USD)
Table 5. Global Insomnia Therapeutics Drugs Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Insomnia Therapeutics Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Insomnia Therapeutics Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Insomnia Therapeutics Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2022)
Table 10. Global Market Insomnia Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Insomnia Therapeutics Drugs Sales Sites and Area Served
Table 12. Manufacturers Insomnia Therapeutics Drugs Product Type
Table 13. Global Insomnia Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Insomnia Therapeutics Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Insomnia Therapeutics Drugs Market Challenges
Table 22. Global Insomnia Therapeutics Drugs Sales by Type (K Units)
Table 23. Global Insomnia Therapeutics Drugs Market Size by Type (M USD)
Table 24. Global Insomnia Therapeutics Drugs Sales (K Units) by Type (2019-2024)
Table 25. Global Insomnia Therapeutics Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Insomnia Therapeutics Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Insomnia Therapeutics Drugs Market Size Share by Type (2019-2024)
Table 28. Global Insomnia Therapeutics Drugs Price (USD/Unit) by Type (2019-2024)
Table 29. Global Insomnia Therapeutics Drugs Sales (K Units) by Application
Table 30. Global Insomnia Therapeutics Drugs Market Size by Application
Table 31. Global Insomnia Therapeutics Drugs Sales by Application (2019-2024) & (K Units)
Table 32. Global Insomnia Therapeutics Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Insomnia Therapeutics Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Insomnia Therapeutics Drugs Market Share by Application (2019-2024)
Table 35. Global Insomnia Therapeutics Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Insomnia Therapeutics Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Global Insomnia Therapeutics Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Insomnia Therapeutics Drugs Sales by Country (2019-2024) & (K Units)
Table 39. Europe Insomnia Therapeutics Drugs Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Insomnia Therapeutics Drugs Sales by Region (2019-2024) & (K Units)
Table 41. South America Insomnia Therapeutics Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Insomnia Therapeutics Drugs Sales by Region (2019-2024) & (K Units)
Table 43. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Basic Information
Table 44. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product Overview
Table 45. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Takeda Pharmaceutical Company Ltd. Business Overview
Table 47. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs SWOT Analysis
Table 48. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 49. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Basic Information
Table 50. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product Overview
Table 51. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Vanda Pharmaceuticals Business Overview
Table 53. Vanda Pharmaceuticals Insomnia Therapeutics Drugs SWOT Analysis
Table 54. Vanda Pharmaceuticals Recent Developments
Table 55. Merck and Co., Inc. Insomnia Therapeutics Drugs Basic Information
Table 56. Merck and Co., Inc. Insomnia Therapeutics Drugs Product Overview
Table 57. Merck and Co., Inc. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Merck and Co., Inc. Insomnia Therapeutics Drugs SWOT Analysis
Table 59. Merck and Co., Inc. Business Overview
Table 60. Merck and Co., Inc. Recent Developments
Table 61. Pfizer Inc. Insomnia Therapeutics Drugs Basic Information
Table 62. Pfizer Inc. Insomnia Therapeutics Drugs Product Overview
Table 63. Pfizer Inc. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Pfizer Inc. Business Overview
Table 65. Pfizer Inc. Recent Developments
Table 66. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Basic Information
Table 67. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product Overview
Table 68. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Teva Pharmaceutical Industries Ltd. Business Overview
Table 70. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 71. Mylan N.V. Insomnia Therapeutics Drugs Basic Information
Table 72. Mylan N.V. Insomnia Therapeutics Drugs Product Overview
Table 73. Mylan N.V. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Mylan N.V. Business Overview
Table 75. Mylan N.V. Recent Developments
Table 76. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Basic Information
Table 77. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product Overview
Table 78. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 80. Sumitomo Dainippon Pharma Co., Ltd Recent Developments
Table 81. Sanofi Insomnia Therapeutics Drugs Basic Information
Table 82. Sanofi Insomnia Therapeutics Drugs Product Overview
Table 83. Sanofi Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sanofi Business Overview
Table 85. Sanofi Recent Developments
Table 86. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Basic Information
Table 87. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product Overview
Table 88. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Paratek Pharmaceuticals Inc. Business Overview
Table 90. Paratek Pharmaceuticals Inc. Recent Developments
Table 91. Ebb Therapeutics Insomnia Therapeutics Drugs Basic Information
Table 92. Ebb Therapeutics Insomnia Therapeutics Drugs Product Overview
Table 93. Ebb Therapeutics Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Ebb Therapeutics Business Overview
Table 95. Ebb Therapeutics Recent Developments
Table 96. Global Insomnia Therapeutics Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Insomnia Therapeutics Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Insomnia Therapeutics Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Insomnia Therapeutics Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Insomnia Therapeutics Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Insomnia Therapeutics Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Insomnia Therapeutics Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Insomnia Therapeutics Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Insomnia Therapeutics Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Insomnia Therapeutics Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Insomnia Therapeutics Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Insomnia Therapeutics Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Insomnia Therapeutics Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Insomnia Therapeutics Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Insomnia Therapeutics Drugs Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Insomnia Therapeutics Drugs Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Insomnia Therapeutics Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Insomnia Therapeutics Drugs Market Size Comparison by Region (M USD)
Table 5. Global Insomnia Therapeutics Drugs Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Insomnia Therapeutics Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Insomnia Therapeutics Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Insomnia Therapeutics Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2022)
Table 10. Global Market Insomnia Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Insomnia Therapeutics Drugs Sales Sites and Area Served
Table 12. Manufacturers Insomnia Therapeutics Drugs Product Type
Table 13. Global Insomnia Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Insomnia Therapeutics Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Insomnia Therapeutics Drugs Market Challenges
Table 22. Global Insomnia Therapeutics Drugs Sales by Type (K Units)
Table 23. Global Insomnia Therapeutics Drugs Market Size by Type (M USD)
Table 24. Global Insomnia Therapeutics Drugs Sales (K Units) by Type (2019-2024)
Table 25. Global Insomnia Therapeutics Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Insomnia Therapeutics Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Insomnia Therapeutics Drugs Market Size Share by Type (2019-2024)
Table 28. Global Insomnia Therapeutics Drugs Price (USD/Unit) by Type (2019-2024)
Table 29. Global Insomnia Therapeutics Drugs Sales (K Units) by Application
Table 30. Global Insomnia Therapeutics Drugs Market Size by Application
Table 31. Global Insomnia Therapeutics Drugs Sales by Application (2019-2024) & (K Units)
Table 32. Global Insomnia Therapeutics Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Insomnia Therapeutics Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Insomnia Therapeutics Drugs Market Share by Application (2019-2024)
Table 35. Global Insomnia Therapeutics Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Insomnia Therapeutics Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Global Insomnia Therapeutics Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Insomnia Therapeutics Drugs Sales by Country (2019-2024) & (K Units)
Table 39. Europe Insomnia Therapeutics Drugs Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Insomnia Therapeutics Drugs Sales by Region (2019-2024) & (K Units)
Table 41. South America Insomnia Therapeutics Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Insomnia Therapeutics Drugs Sales by Region (2019-2024) & (K Units)
Table 43. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Basic Information
Table 44. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product Overview
Table 45. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Takeda Pharmaceutical Company Ltd. Business Overview
Table 47. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs SWOT Analysis
Table 48. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 49. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Basic Information
Table 50. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product Overview
Table 51. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Vanda Pharmaceuticals Business Overview
Table 53. Vanda Pharmaceuticals Insomnia Therapeutics Drugs SWOT Analysis
Table 54. Vanda Pharmaceuticals Recent Developments
Table 55. Merck and Co., Inc. Insomnia Therapeutics Drugs Basic Information
Table 56. Merck and Co., Inc. Insomnia Therapeutics Drugs Product Overview
Table 57. Merck and Co., Inc. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Merck and Co., Inc. Insomnia Therapeutics Drugs SWOT Analysis
Table 59. Merck and Co., Inc. Business Overview
Table 60. Merck and Co., Inc. Recent Developments
Table 61. Pfizer Inc. Insomnia Therapeutics Drugs Basic Information
Table 62. Pfizer Inc. Insomnia Therapeutics Drugs Product Overview
Table 63. Pfizer Inc. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Pfizer Inc. Business Overview
Table 65. Pfizer Inc. Recent Developments
Table 66. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Basic Information
Table 67. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product Overview
Table 68. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Teva Pharmaceutical Industries Ltd. Business Overview
Table 70. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 71. Mylan N.V. Insomnia Therapeutics Drugs Basic Information
Table 72. Mylan N.V. Insomnia Therapeutics Drugs Product Overview
Table 73. Mylan N.V. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Mylan N.V. Business Overview
Table 75. Mylan N.V. Recent Developments
Table 76. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Basic Information
Table 77. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product Overview
Table 78. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 80. Sumitomo Dainippon Pharma Co., Ltd Recent Developments
Table 81. Sanofi Insomnia Therapeutics Drugs Basic Information
Table 82. Sanofi Insomnia Therapeutics Drugs Product Overview
Table 83. Sanofi Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sanofi Business Overview
Table 85. Sanofi Recent Developments
Table 86. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Basic Information
Table 87. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product Overview
Table 88. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Paratek Pharmaceuticals Inc. Business Overview
Table 90. Paratek Pharmaceuticals Inc. Recent Developments
Table 91. Ebb Therapeutics Insomnia Therapeutics Drugs Basic Information
Table 92. Ebb Therapeutics Insomnia Therapeutics Drugs Product Overview
Table 93. Ebb Therapeutics Insomnia Therapeutics Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Ebb Therapeutics Business Overview
Table 95. Ebb Therapeutics Recent Developments
Table 96. Global Insomnia Therapeutics Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Insomnia Therapeutics Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Insomnia Therapeutics Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Insomnia Therapeutics Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Insomnia Therapeutics Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Insomnia Therapeutics Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Insomnia Therapeutics Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Insomnia Therapeutics Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Insomnia Therapeutics Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Insomnia Therapeutics Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Insomnia Therapeutics Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Insomnia Therapeutics Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Insomnia Therapeutics Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Insomnia Therapeutics Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Insomnia Therapeutics Drugs Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Insomnia Therapeutics Drugs Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Insomnia Therapeutics Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Insomnia Therapeutics Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Insomnia Therapeutics Drugs Market Size (M USD), 2019-2030
Figure 5. Global Insomnia Therapeutics Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Insomnia Therapeutics Drugs Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Insomnia Therapeutics Drugs Market Size by Country (M USD)
Figure 11. Insomnia Therapeutics Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Insomnia Therapeutics Drugs Revenue Share by Manufacturers in 2023
Figure 13. Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Insomnia Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Insomnia Therapeutics Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Insomnia Therapeutics Drugs Market Share by Type
Figure 18. Sales Market Share of Insomnia Therapeutics Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Insomnia Therapeutics Drugs by Type in 2023
Figure 20. Market Size Share of Insomnia Therapeutics Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Insomnia Therapeutics Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Insomnia Therapeutics Drugs Market Share by Application
Figure 24. Global Insomnia Therapeutics Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Insomnia Therapeutics Drugs Sales Market Share by Application in 2023
Figure 26. Global Insomnia Therapeutics Drugs Market Share by Application (2019-2024)
Figure 27. Global Insomnia Therapeutics Drugs Market Share by Application in 2023
Figure 28. Global Insomnia Therapeutics Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Insomnia Therapeutics Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Insomnia Therapeutics Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Insomnia Therapeutics Drugs Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Insomnia Therapeutics Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Insomnia Therapeutics Drugs Sales Market Share by Country in 2023
Figure 37. Germany Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Insomnia Therapeutics Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Insomnia Therapeutics Drugs Sales Market Share by Region in 2023
Figure 44. China Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Insomnia Therapeutics Drugs Sales and Growth Rate (K Units)
Figure 50. South America Insomnia Therapeutics Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Insomnia Therapeutics Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Insomnia Therapeutics Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Insomnia Therapeutics Drugs Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Insomnia Therapeutics Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Insomnia Therapeutics Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Insomnia Therapeutics Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Insomnia Therapeutics Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Insomnia Therapeutics Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Insomnia Therapeutics Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Insomnia Therapeutics Drugs Market Size (M USD), 2019-2030
Figure 5. Global Insomnia Therapeutics Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Insomnia Therapeutics Drugs Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Insomnia Therapeutics Drugs Market Size by Country (M USD)
Figure 11. Insomnia Therapeutics Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Insomnia Therapeutics Drugs Revenue Share by Manufacturers in 2023
Figure 13. Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Insomnia Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Insomnia Therapeutics Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Insomnia Therapeutics Drugs Market Share by Type
Figure 18. Sales Market Share of Insomnia Therapeutics Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Insomnia Therapeutics Drugs by Type in 2023
Figure 20. Market Size Share of Insomnia Therapeutics Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Insomnia Therapeutics Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Insomnia Therapeutics Drugs Market Share by Application
Figure 24. Global Insomnia Therapeutics Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Insomnia Therapeutics Drugs Sales Market Share by Application in 2023
Figure 26. Global Insomnia Therapeutics Drugs Market Share by Application (2019-2024)
Figure 27. Global Insomnia Therapeutics Drugs Market Share by Application in 2023
Figure 28. Global Insomnia Therapeutics Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Insomnia Therapeutics Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Insomnia Therapeutics Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Insomnia Therapeutics Drugs Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Insomnia Therapeutics Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Insomnia Therapeutics Drugs Sales Market Share by Country in 2023
Figure 37. Germany Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Insomnia Therapeutics Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Insomnia Therapeutics Drugs Sales Market Share by Region in 2023
Figure 44. China Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Insomnia Therapeutics Drugs Sales and Growth Rate (K Units)
Figure 50. South America Insomnia Therapeutics Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Insomnia Therapeutics Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Insomnia Therapeutics Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Insomnia Therapeutics Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Insomnia Therapeutics Drugs Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Insomnia Therapeutics Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Insomnia Therapeutics Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Insomnia Therapeutics Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Insomnia Therapeutics Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Insomnia Therapeutics Drugs Market Share Forecast by Application (2025-2030)
